ethosuximide has been researched along with Hyperostosis Frontalis Interna in 1 studies
Ethosuximide: An anticonvulsant especially useful in the treatment of absence seizures unaccompanied by other types of seizures.
ethosuximide : A dicarboximide that is pyrrolidine-2,5-dione in which the hydrogens at position 3 are substituted by one methyl and one ethyl group. An antiepileptic, it is used in the treatment of absence seizures and may be used for myoclonic seizures, but is ineffective against tonic-clonic seizures.
Hyperostosis Frontalis Interna: Thickening of the inner table of the frontal bone, which may be associated with hypertrichosis and obesity. It most commonly affects women near menopause.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nakanishi M, S | 1 |
| Neshige, R | 1 |
| Kuroda, Y | 1 |
| Inoue, Y | 1 |
1 other study available for ethosuximide and Hyperostosis Frontalis Interna
| Article | Year |
|---|---|
[A case of adult-onset spike-wave stupor associated with hypoparathyroidism and hyperostosis frontalis interna (HFI)].
Topics: Adult; Electroencephalography; Epilepsy, Absence; Ethosuximide; Female; Humans; Hyperostosis Frontal | 1990 |